Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01566682 · ClinicalTrials.gov registry record
A Multi-Center Trial of the ProLung Test™
A clinical trial of Multiple Pulmonary Nodules and Solitary Pulmonary Nodule, sponsored by Fresh Medical Laboratories.
- Completed
- Registry status
- 420
- Enrollment target
- 15
- Study locations
NCT01566682: Completed study of Multiple Pulmonary Nodules and Solitary Pulmonary Nodule, sponsored by Fresh Medical Laboratories.
NCT01566682 is a study of Multiple Pulmonary Nodules and Solitary Pulmonary Nodule that has completed, run by Fresh Medical Laboratories. The registered enrollment target is 420 participants, below the 916-participant average among 4 other Multiple Pulmonary Nodules trials with a reported enrollment target (54% lower). The trial reports 15 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01566682, a study of Multiple Pulmonary Nodules and Solitary Pulmonary Nodule, has completed, sponsored by Fresh Medical Laboratories.
- COMPLETED
- Registry status
- 420 participants
- Enrollment target
- 15
- Study locations
Study Summary
The primary Study hypothesis is that the ProLung Test will demonstrate safety and efficacy in the risk stratification of patients with pulmonary lesions identified by CT that are suspicious for lung cancer. A statistically significant result will indicate that patients with a high ProLung Test result have a greater risk of developing lung cancer than patients with a low test result. There are three Specific Aims of this study: 1. Optimize and confirm the stability of the ProLung Test risk-stratification algorithm in patients with a diagnosis. 2. Externally validate the efficacy of the ProLung Test risk-stratification algorithm by comparing the test result to the conclusive patient diagnosis. 3. Assess the safety and tolerability of the ProLung Test procedures. Study Design This Study consists of two distinct phases, Stabilization and Validation. The Study will collect data from multiple sites (3 to 12), and each site may enroll patients and collect data for the Stabilization and Validation Phases with a minimum of three sites for the Validation Phase.
Primary Outcome
Demonstrate safety and efficacy in the risk stratification of patients with pulmonary lesions identified by CT that are suspicious for lung cancer.
Conditions Studied
Study Locations (15)
California
- UCLA Medical Center - Los Angeles
- UCSD Medical Center - San Diego
- Stanford University Medical Center - Stanford
Minnesota
- University of Minnesota Masonic Cancer Center - Minneapolis
- Mayo Clinic - Rochester
Texas
- MD Anderson Cancer Center - Houston
- Providence Health Center - Waco
Utah
- Intermountain Healthcare - Murray
- Huntsman Cancer Institute - Salt Lake City
Illinois
- Loyola University Medical Center - Maywood
Maryland
- Greater Baltimore Medical Center - Towson
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Michigan
- Henry Ford Medical Center - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2012-10 |
| Est. Completion | 2019-03 |
What the finished NCT01566682 record still lists
NCT01566682 is an observational study that tracks outcomes without assigning an intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap, below the 916-participant average among 4 other Multiple Pulmonary Nodules trials with a reported enrollment target (54% lower).
The record links to 2 conditions, with Multiple Pulmonary Nodules appearing as the primary indexed condition, and to 0 interventions.
NCT01566682 lists 15 locations in 10 states (California, Minnesota, Texas).
Frequently Asked Questions
What is clinical trial NCT01566682 about?
NCT01566682 is a clinical study titled "A Multi-Center Trial of the ProLung Test™". The primary Study hypothesis is that the ProLung Test will demonstrate safety and efficacy in the risk stratification of patients with pulmonary lesions identified by CT that are suspicious for lung cancer. A statistically significant result will indicate that patients with a high ProLung Test resul...
What is the current status of trial NCT01566682?
This trial is currently completed. The enrollment target is 420 participants. The study started on 2012-10. Estimated completion is 2019-03.
What conditions does trial NCT01566682 study?
This clinical trial studies the following conditions: Multiple Pulmonary Nodules, Solitary Pulmonary Nodule.
Who is sponsoring clinical trial NCT01566682?
This trial is sponsored by Fresh Medical Laboratories, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01566682 being conducted?
This trial has 15 study locations across California, Illinois, Maryland, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Pulmonary Nodules
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules
ACTIVE NOT RECRUITING
-
Teachable Moment to Opt-out of Tobacco: Interactive Voice Response Quit Line for Veteran Active Smokers With Lung Nodules
ACTIVE NOT RECRUITING · NA
-
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
- NCT04149743 · 420 participants · NA
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia